151 related articles for article (PubMed ID: 35247713)
1. Substrate-specific presentation of MHC class I-restricted antigens via autophagy pathway.
Tovar Fernandez MC; Sroka EM; Lavigne M; Thermou A; Daskalogianni C; Manoury B; Prado Martins R; Fahraeus R
Cell Immunol; 2022 Apr; 374():104484. PubMed ID: 35247713
[TBL] [Abstract][Full Text] [Related]
2. Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.
Apcher S; Daskalogianni C; Manoury B; Fåhraeus R
PLoS Pathog; 2010 Oct; 6(10):e1001151. PubMed ID: 20976201
[TBL] [Abstract][Full Text] [Related]
3. A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus.
Voisset C; Daskalogianni C; Contesse MA; Mazars A; Arbach H; Le Cann M; Soubigou F; Apcher S; Fåhraeus R; Blondel M
Dis Model Mech; 2014 Apr; 7(4):435-44. PubMed ID: 24558096
[TBL] [Abstract][Full Text] [Related]
4. ATG5 is required for B cell polarization and presentation of particulate antigens.
Arbogast F; Arnold J; Hammann P; Kuhn L; Chicher J; Murera D; Weishaar J; Muller S; Fauny JD; Gros F
Autophagy; 2019 Feb; 15(2):280-294. PubMed ID: 30196744
[TBL] [Abstract][Full Text] [Related]
5. Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1.
Tellam JT; Lekieffre L; Zhong J; Lynn DJ; Khanna R
PLoS Pathog; 2012 Dec; 8(12):e1003112. PubMed ID: 23300450
[TBL] [Abstract][Full Text] [Related]
6. Differential use of autophagy by primary dendritic cells specialized in cross-presentation.
Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA
Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899
[TBL] [Abstract][Full Text] [Related]
7. Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells.
Oh DS; Lee HK
Autophagy; 2019 Dec; 15(12):2091-2106. PubMed ID: 30900506
[TBL] [Abstract][Full Text] [Related]
8. Generation of both MHC class I- and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes.
Muno D; Kominami E; Mizuochi T
FEBS Lett; 2000 Jul; 478(1-2):178-82. PubMed ID: 10922492
[TBL] [Abstract][Full Text] [Related]
9. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.
Quinn LL; Williams LR; White C; Forrest C; Zuo J; Rowe M
J Virol; 2016 Jan; 90(1):356-67. PubMed ID: 26468525
[TBL] [Abstract][Full Text] [Related]
10. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
[TBL] [Abstract][Full Text] [Related]
11. Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing.
Khanna R; Burrows SR; Steigerwald-Mullen PM; Moss DJ; Kurilla MG; Cooper L
Int Immunol; 1997 Oct; 9(10):1537-43. PubMed ID: 9352359
[TBL] [Abstract][Full Text] [Related]
12. Viral immune evasion: Lessons in MHC class I antigen presentation.
van de Weijer ML; Luteijn RD; Wiertz EJ
Semin Immunol; 2015 Mar; 27(2):125-37. PubMed ID: 25887630
[TBL] [Abstract][Full Text] [Related]
13. Involvement of autophagy in MHC class I antigen presentation.
Øynebråten I
Scand J Immunol; 2020 Nov; 92(5):e12978. PubMed ID: 32969499
[TBL] [Abstract][Full Text] [Related]
14. Role of autophagy in MHC class I-restricted antigen presentation.
Van Kaer L; Parekh VV; Postoak JL; Wu L
Mol Immunol; 2019 Sep; 113():2-5. PubMed ID: 29126597
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
[TBL] [Abstract][Full Text] [Related]
16. ATGs help MHC class II, but inhibit MHC class I antigen presentation.
Loi M; Gannagé M; Münz C
Autophagy; 2016 Sep; 12(9):1681-2. PubMed ID: 27439741
[TBL] [Abstract][Full Text] [Related]
17. Endogenous MHC class II processing of a viral nuclear antigen after autophagy.
Paludan C; Schmid D; Landthaler M; Vockerodt M; Kube D; Tuschl T; Münz C
Science; 2005 Jan; 307(5709):593-6. PubMed ID: 15591165
[TBL] [Abstract][Full Text] [Related]
18. Canonical and Non-Canonical Functions of the Autophagy Machinery in MHC Restricted Antigen Presentation.
Münz C
Front Immunol; 2022; 13():868888. PubMed ID: 35309359
[TBL] [Abstract][Full Text] [Related]
19. Autophagy and MHC-restricted antigen presentation.
Valečka J; Almeida CR; Su B; Pierre P; Gatti E
Mol Immunol; 2018 Jul; 99():163-170. PubMed ID: 29787980
[TBL] [Abstract][Full Text] [Related]
20. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
McMenamin C; Holt PG
J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
